Search Results - "Fallan C"

Accelerated synthesis of immunomodulatory imide drugs and their derivatives via continuous flow chemistry.

Authors: Hou, Tianyi Huang, Junrong Li, Yongheng et al.

Source: Communications Chemistry. 3/3/2026, Vol. 9 Issue 1, p1-10. 10p.

Indirect ubiquitination independent of endogenous ubiquitination machinery for targeted protein degradation.

Authors: Furuhata, Takafumi Yoshida, Kazuki Fujita, Ryoka et al.

Source: Communications Chemistry. 1/29/2026, Vol. 9 Issue 1, p1-10. 10p.

Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors.

Authors: Gupta, Nishma Trainor, Nicole Radwan, Mona et al.

Source: Communications Chemistry. 1/19/2026, Vol. 9 Issue 1, p1-23. 23p.

Exploring the macrocyclic chemical space for heuristic drug design with deep learning models.

Authors: Hu, Feng Jia, Xiaotong Liao, Wenjie et al.

Source: Communications Chemistry. 10/7/2025, Vol. 8 Issue 1, p1-11. 11p.

Sweat Characteristics and Fluid Balance Responses During Two Heat Training Camps in Elite Female Field Hockey Players.

Authors: Goods, Paul S.R. Wall, Bradley Galna, Brook et al.

Source: International Journal of Sport Nutrition & Exercise Metabolism. Mar2024, Vol. 34 Issue 2, p79-87.

Synthesis of new bis(triethylphosphine)platinum(II) complexes containing heterocyclic selenones as potential inhibitors of human cancer: Experimental and theoretical investigations.

Authors: Sulaiman, Adam A. A. Bhatia, Gaurav Fettouhi, Mohammed et al.

Source: Journal of King Saud University - Science. May2026, Vol. 38 Issue 5, p1-14. 14p.

PROTAC-Mediated Targeted Degradation of MDM2 Induces Tumor-Suppressive Signaling in Osteosarcoma Cells.

Authors: Kim, Yeongji Kim, Jin-Woo Choi, Junwon et al.

Source: Cells (2073-4409). Mar2026, Vol. 15 Issue 5, p473. 23p.

Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems.

Authors: Yao TT Zhou Z Wang GJ et al.

Source: Acta pharmacologica Sinica [Acta Pharmacol Sin] 2026 Jun 25. Date of Electronic Publication: 2026 Jun 25.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE

Patterns of Nutritional Supplement Use in Turkish Handball Players: Influence of Sex and Competition Level Based on the AIS Classification System.

Authors: Mor, Ömer Sanchez-Oliver, Antonio Jesus Bayraktar, Bülent et al.

Source: Applied Sciences (2076-3417); Oct2025, Vol. 15 Issue 20, p11061, 19p

Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics.

Authors: Sharma, Ram Mishra, Anshul Bhardwaj, Monika et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-49. 49p.

Design and synthesis of novel HDAC6 inhibitor dimer as HDAC6 degrader for cancer treatment by palladium catalysed dimerisation.

Authors: Lin, Ching Hsu, Jui-Ling Hsu, Yu-Tung et al.

Source: Journal of Enzyme Inhibition & Medicinal Chemistry. Dec2025, Vol. 40 Issue 1, p1-15. 15p.

Synthesis and Evaluation of AS1411-Lenalidomide-Targeted Degradation Chimera in Antitumor Therapy.

Authors: Ma, Xueling Liu, Shuangshuang Dong, Xiao et al.

Source: Pharmaceuticals (14248247). Dec2025, Vol. 18 Issue 12, p1867. 15p.

Diisopropyl (E)-(1-Hydroxy-3-phenylallyl)phosphonate.

Authors: Coker, Andy I. McKay, Aidan P. Cordes, David B. et al.

Source: Molbank. Jun2025, Vol. 2025 Issue 2, pM2013. 7p.

Spotlighting rising researcher Martin Screen: investigating solid form and formulation strategies for PROTACs.

Authors: Screen, Martin A.¹ (AUTHOR) martin.screen@thermofisher.com

Source: AAPS Open. 3/11/2026, Vol. 12 Issue 1, p1-3. 3p.

Knowledge mapping and bibliometric insights of scientific research on targeted protein degradation in oncology.

Authors: Sweileh MW; Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, Palestine. moutazsweileh@najah.edu.; Department of Pathology, An-Najah National University Hospital, Nablus, Palestine. moutazsweileh@najah.edu.

Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2026 Apr 27; Vol. 152 (4). Date of Electronic Publication: 2026 Apr 27.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335 (Electronic) Linking ISSN: 01715216 NLM ISO Abbreviation: J Cancer Res Clin Oncol Subsets: MEDLINE

Mapping Scientific Landscapes and Therapeutic Innovations of Targeted Protein Degradation: A Scientometric Review.

Authors: Li, Chong Wang, Xiangxiu He, Anqi et al.

Source: Pharmaceutics. Jul2026, Vol. 18 Issue 7, p887. 35p.

Linking ATP and allosteric sites to achieve superadditive binding with bivalent EGFR kinase inhibitors.

Authors: Wittlinger, Florian Ogboo, Blessing C. Shevchenko, Ekaterina et al.

Source: Communications Chemistry. 2/20/2024, Vol. 7 Issue 1, p1-14. 14p.

Recent Advances in the Development of Pro-PROTAC for Selective Protein Degradation.

Authors: Hakem, Fady Abdelwaly, Ahmad Alshaman, Reem et al.

Source: Pharmaceutics. Sep2025, Vol. 17 Issue 9, p1160. 19p.

Pyrrolopyrimidines: Design, Synthesis and Antitumor Properties of Novel Tricyclic Pyrrolo [2,3- d ]pyrimidine Derivatives.

Authors: Song, Buer Murtazaeva, Zarifa Nie, Lifei et al.

Source: Molecules. Jul2025, Vol. 30 Issue 14, p2917. 18p.

Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses.

Authors: Feyles, Elisa Felicetti, Tommaso Arduino, Irene et al.

Source: Viruses (1999-4915). Jul2025, Vol. 17 Issue 7, p890. 15p.